Clinical Practice

Retesting: When a Second Food Marker Panel Earns Its Place

A follow-up food marker panel is useful in some situations and redundant in others. How clinicians decide when to repeat testing, and what a second set of results can and cannot settle.

The question comes up sooner than most clinicians expect. A patient finishes an elimination phase, feels different, and asks when they should test again. Sometimes the request arrives before any dietary change has been sustained long enough to matter. Either way, you need a position on retesting, and it is better to have one before the patient asks than to improvise in the room.

A second IS382 COMPLETE panel measures the same four markers as the first: IgE for immediate allergy, IgG and IgG4 for delayed sensitivity, and complement C3b/d. Repeating it gives you a new set of numbers. What it does not give you is an independent verdict on whether the plan worked. That judgement still belongs to you, and it draws on the patient's reported symptoms, their adherence, and everything else you know about them.

What a second panel can reasonably tell you

The markers on the panel respond to different things and on different timescales. IgG and IgG4 levels are tied to ongoing exposure, so a genuine change in what a patient eats can be reflected in a later measurement. IgE reactivity to a food tends to be more persistent, which is one reason an immediate-type reaction is treated as a standing precaution rather than something to be tested out of.

Complement C3b/d deserves separate attention. Where complement activation is in play, it can amplify a reaction substantially, which means a food with a modest antibody signal may still be clinically noisy. If the first panel showed complement involvement, a follow-up gives you a look at whether that amplifying layer has quietened alongside the antibody picture. That is a more interesting question than whether any single food moved a few units.

What a second panel cannot do is confirm that a food is now safe or that a sensitivity has resolved. Markers moving in a favourable direction is information. Deciding what it means for this patient's diet is clinical work.

The situations that usually justify it

In practice, a repeat panel earns its place in a narrow set of circumstances:

• The clinical picture has changed materially and you cannot account for it from the first panel and the food diary alone.
• A structured elimination and reintroduction sequence has been completed and you want an objective input before agreeing a longer-term eating pattern.
• Symptoms improved and then returned, and you suspect the reactive picture has shifted rather than adherence having slipped.

The most common reason to decline is simpler: not enough has changed. If the patient has not held an elimination phase consistently, a new panel will largely restate the first one, and you will have spent the patient's goodwill on a result that does not move the plan forward. Saying so plainly tends to land well. Patients generally understand that a test measures what is happening now, and that nothing much has happened yet.

Dietitians: retesting as a defined checkpoint

For a dietitian running a virtual service, retesting is easier to handle as a named stage in the programme than as an open question. If the offer says the panel is repeated at the end of a structured reintroduction period, when clinically indicated, the patient knows what to expect and you are not negotiating it individually every time. At-home serum collection makes this practical, because the second draw does not require the patient to travel to you and does not add a room to your operation. It adds a review consultation, which is billable work you are already equipped to do.

That framing also protects the clinical logic. The checkpoint exists because there is a decision to make at that point, not because a calendar interval elapsed.

Chiropractors: let the presentation drive it

In a chiropractic setting, where food markers are usually being considered alongside recurrent soft tissue or inflammatory complaints, symptom-led retesting makes more sense than scheduled retesting. If a patient's flare pattern changes after dietary modification, that is a reason to look again. If the pattern is unchanged, the more useful next step is often to examine adherence and load rather than to order another panel. Retesting is not a way to find something the first panel missed.

Covered populations: available is not the same as indicated

Where union members can access testing at no cost through insurance, the friction that normally limits repeat testing is absent. That puts more weight on clinical judgement, not less. Coverage answers the question of who pays. It does not answer whether a second measurement will change what you do. Documenting your reasoning for each panel, first or second, keeps the service line defensible and keeps the results meaningful to the members using it.

Write the criteria down

The cleanest approach is to decide, in advance and in writing, what would make you repeat a panel and what would not. Two or three criteria are enough. It shortens the conversation with patients, keeps your protocol consistent across a growing caseload, and means the second panel arrives with a question attached rather than a hope that the numbers will say something useful on their own.